Funding news
Nucleai logo

Nucleai Raises $14.0M to Advance AI-

Recently funded · $14.0M UnknownTechnology, Information and MediaUSView source

Get the full Nucleai company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Nucleai, a company leveraging AI-powered spatial biology to tackle challenges in precision medicine, has secured $14.0M in new investment. Its Atom platform, described as a leading spatial biology platform, is licensed to major pharmaceutical companies for internal research and used in collaborations for biomarker discovery projects.

The company's core mission is to improve drug development, clinical treatment decisions, and patient outcomes. This latest capital infusion will support Nucleai's ongoing efforts to bring advanced analytics to the forefront of medical research, enhancing the discovery of critical biomarkers.

Other United States companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
Illumina logo

Illumina

United States

$7.1B
4
GRAIL logo

GRAIL

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Unknown rounds

Companies that recently closed a Unknown round.

#CompanyAmount
1
Airtap AI logo

Airtap AI

United States

$100.0K
2
MRTNZ Souliers Martinez logo

MRTNZ Souliers Martinez

France

$100.0K
3
Nimbles logo

Nimbles

$100.0K
4
NEO Finance logo

NEO Finance

Lithuania

$79.6K
5
LiteBit logo

LiteBit

$100.0K